A panel of 4 clinicians with experience in pediatric pulmonology discuss current research findings and gaps in studies of pediatric obstructive sleep apnea, particularly regarding cardiovascular risk.
In a trial, empagliflozin reduced the risks for heart failure hospitalization and renal outcomes in patients with heart failure with reduced ejection fraction.
As cardiorespiratory fitness declines among US youth, researchers explore methods for assessing cardiorespiratory fitness in otherwise healthy children.
For anti-SSA/Ro-positive mothers with a previous pregnancy complicated by congenital heart block (CHB), hydroxychloroquine may reduce the recurrence of CHB.
Researchers evaluated blood pressure dipping as a marker of endothelial function and subclinical atherosclerosis in pediatric-onset systemic lupus erythematosus.
